The unit of Novartis, Switzerland's largest drug company, has agreed to buy Canadian generic drug maker Holdings Ltd. for 312 million Canadian dollars Lrb about 587 million us dollars Rrb, reports here said Tuesday.
Swiss company buys Canadian generic drug maker.